Drugs / GeniusVac-Mel4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01863108 | Jun 2013 → Mar 2017 | melanoma | University Hospital, Grenoble | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GeniusVac-Mel4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01863108 ↗ |
| Modality | Vaccine | “GeniusVac-Mel4, a dendritic cell-based cancer vaccine” NCT01863108 ↗ |
| Route | Subcutaneous | “Multiple sub-cutaneous injections” NCT01863108 ↗ |